![Kura Oncology Inc](/common/images/company/N_KURA.png)
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progressi... Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. The company has a lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through the United States. Show more
SAN DIEGO, July 05, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
– Ziftomenib induces insulin production, improves insulin sensitivity and reduces insulin resistance in preclinical model of type 2 diabetes – – Kura advancing multiple, next-generation menin...
SAN DIEGO, June 07, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.6 | -2.91120815138 | 20.61 | 21.37 | 19.83 | 1282253 | 20.64002532 | CS |
4 | -1.54 | -7.14617169374 | 21.55 | 22.6 | 19.41 | 844309 | 20.82232844 | CS |
12 | -0.29 | -1.42857142857 | 20.3 | 23.1 | 16.79 | 763270 | 20.34966077 | CS |
26 | 4.52 | 29.180116204 | 15.49 | 24.17 | 13.29 | 1096922 | 20.05649179 | CS |
52 | 9.41 | 88.7735849057 | 10.6 | 24.17 | 7.41 | 947151 | 15.89144783 | CS |
156 | -1.25 | -5.87958607714 | 21.26 | 24.17 | 7.41 | 837091 | 15.01532074 | CS |
260 | -0.15 | -0.744047619048 | 20.16 | 43 | 6.34 | 723200 | 17.8506048 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.